EMA Write PMS API Implementation Guide - Enrichments
1.2.0 - ci-build

EMA Write PMS API Implementation Guide - Enrichments - Local Development build (v1.2.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 Examples
... 3 Artifacts Summary
.... 3.1 EMA Write API ActivityDefinition
.... 3.2 EMA Write API ActivityDefinition Restrictions
.... 3.3 EMA Write API Marketing Regulated Authorization
.... 3.4 EMA Write API MedicinalProductDefinition
.... 3.5 EMA Write API MedicinalProductDefinition Restrictions
.... 3.6 EMA Write API PackagedProductDefinition
.... 3.7 EMA Write API PackagedProductDefinition
.... 3.8 EMA Write API Regulated Authorization
.... 3.9 EMA Write PMS API Bundle
.... 3.10 EMA Write PMS API Bundle Restrictions
.... 3.11 EMA AdditionalMonitoringIndicator boolean CodeableConcept
.... 3.12 EMA API V2 Identifier
.... 3.13 EMA Application Identifier Number
.... 3.14 EMA ATC Coding
.... 3.15 EMA Coding
.... 3.16 EMA Coding Restrictions
.... 3.17 EMA Duration
.... 3.18 EMA Eudra GMP Number Identifier
.... 3.19 EMA EURD Identifier
.... 3.20 EMA Generic ReferentialTerm CodeableConcept
.... 3.21 EMA Generic ReferentialTerm CodeableConcept restrictions
.... 3.22 EMA Genetically Modified Organisms CodeableConcept
.... 3.23 EMA Identifier Restrictions
.... 3.24 EMA Legal Basis CodeableConcept
.... 3.25 EMA Light ATC CodeableConcept
.... 3.26 EMA Manufacturing Authorization Number Identifier
.... 3.27 EMA Marketing Authorization Identifier
.... 3.28 EMA Master File Identifier
.... 3.29 EMA Master File Identifier Restrictions
.... 3.30 EMA Master Identifier
.... 3.31 EMA MP Identifier
.... 3.32 EMA PC Identifier
.... 3.33 EMA Period
.... 3.34 EMA Period restrictions
.... 3.35 EMA Pharmacovigilance Qualified Person Type CodeableConcept
.... 3.36 EMA Pharmacovigilance Qualified Person Type CodeableConcept
.... 3.37 EMA Product Category CodeableConcept
.... 3.38 EMA Quantity
.... 3.39 EMA Ratio
.... 3.40 EMA Reference Restrictions
.... 3.41 EMA XEVMPD Product CodeableConcept
.... 3.42 The MPD Name Part Type Coding
.... 3.43 Authorised Dose Form
.... 3.44 Code System Name
.... 3.45 Date of Update extension
.... 3.46 Language
.... 3.47 Marketing Status Reason
.... 3.48 MedicinalProductDefiniton - MasterFile
.... 3.49 Regulated Authorization - Date of First Authorisation
.... 3.50 Regulated Authorization - International Birth Date
.... 3.51 Regulated Authorization - Paediatric - Reference Country
.... 3.52 Risk of Supply Shortage
.... 3.53 Risk of Supply Shortage Comment
.... 3.54 Submission Date extension
.... 3.55 Term Version
.... 3.56 The ATC Pending Extension
.... 3.57 The Comparator Extension
.... 3.58 The Complies with directive Extension
.... 3.59 The Ingredient Annex 5.10 Extension
.... 3.60 The Ingredient Annex 5.11 Extension
.... 3.61 The Ingredient Annex 5.20 Extension
.... 3.62 The Ingredient Annex 5.23 Extension
.... 3.63 The Ingredient Documentation Extension
.... 3.64 The Ingredient's Origin of Substance Extension
.... 3.65 The Operation Extension
.... 3.66 The Package Shelf Life Duration Extension
.... 3.67 Additional Monitoring Indicator
.... 3.68 Application Submission Type
.... 3.69 Authorised Dose Form
.... 3.70 Combined Pharmaceutical Dose Form
.... 3.71 Country
.... 3.72 Data Classification
.... 3.73 Documentation
.... 3.74 Domain
.... 3.75 Genetically Modified Organism
.... 3.76 Ingredient Role
.... 3.77 Language
.... 3.78 Legal Status of Supply
.... 3.79 Manufacturing Activity
.... 3.80 Marketing and Manufacturing types
.... 3.81 Marketing Status
.... 3.82 Marketing Status Reason
.... 3.83 Master File Identifier Type
.... 3.84 Master File Type
.... 3.85 Master File Type + DocumentType
.... 3.86 Material
.... 3.87 Medicinal Product Name Part Type
.... 3.88 Medicinal Product Type
.... 3.89 Packaging
.... 3.90 Paediatric Use Indicator
.... 3.91 Pharmaceutical Dose Form
.... 3.92 Product Category
.... 3.93 Product Cross Reference Type
.... 3.94 Promotion
.... 3.95 Quantity Operator
.... 3.96 Record Status
.... 3.97 Regulatory Authorization Registration Procedure
.... 3.98 Regulatory Entitlement Status
.... 3.99 Regulatory Entitlement Type
.... 3.100 Shelf Life Type
.... 3.101 Special Precautions For Storage
.... 3.102 Substance Origin
.... 3.103 Supply
.... 3.104 Unit of Measurement
.... 3.105 Units of Presentation
.... 3.106 XEVMPD medicinal product type
.... 3.107 XEVMPD medicinal product type
.... 3.108 Additional Monitoring Indicator
.... 3.109 Application Submission Type
.... 3.110 Combination Package
.... 3.111 Combined Pharmaceutical Dose Form
.... 3.112 Combined Term
.... 3.113 Contact Type
.... 3.114 Country
.... 3.115 Data Classification
.... 3.116 Document Type
.... 3.117 Documentation
.... 3.118 Domain
.... 3.119 Genetically Modified Organism
.... 3.120 Ingredient Role
.... 3.121 Language
.... 3.122 Legal Status From the Supply
.... 3.123 Manufacturing Activity Value Set
.... 3.124 Marketing Authorisation Application Legal Basis
.... 3.125 Marketing Status
.... 3.126 Master File Identifier Type
.... 3.127 Master File Type
.... 3.128 Material
.... 3.129 Medicinal Product Name Part Type
.... 3.130 Medicinal Product Type
.... 3.131 Packaging
.... 3.132 Paediatric Use Indicator
.... 3.133 Pharmaceutical Dose Form
.... 3.134 Product Category
.... 3.135 Product Cross Reference Type
.... 3.136 Promotion
.... 3.137 Quantity Operator
.... 3.138 Reason for Marketing Unavailability
.... 3.139 Record Status
.... 3.140 Regulatory Authorization Registration Procedure
.... 3.141 Regulatory Entitlement
.... 3.142 Regulatory Entitlement Status
.... 3.143 Shelf Life Type
.... 3.144 Special Precautions for Storage
.... 3.145 Substance Origin
.... 3.146 Supply
.... 3.147 Unit Of Measurement Value Set
.... 3.148 Units Of Presentation
.... 3.149 XEVMPD Medicinal Product Type
.... 3.150 1. Get Product Bundle
.... 3.151 2. Change pack size
.... 3.152 3. Change pack size (response)
.... 3.153 4. Add manufacturing operation
.... 3.154 5. Add manufacturing operation (response)
.... 3.155 ActivityDefinition
.... 3.156 DocumentReference
.... 3.157 DocumentReference
.... 3.158 Organization
.... 3.159 PractitionerRole